O2 sensing and angiogenesis Flashcards

1
Q

Oxygen essential component for life on earth

A

Proving fundamantal element in the survival of aerobic organisms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

The circulatory system provides an important mechanism for the transport of oxygen to the cells of the body

A

with blood vessels acting as the transport routes for delivery of oxygen to the tissues

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Angiogenesis describes the formation of new blood vessels from pre-existing vessels

A

Following discovery in 1971 by Folkov, the phenomenon was initially thought to be a non-specific by-product of inflammation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

However the research community has since recongised the importance of angiogenesis in health and disease

A

In healthy individuals, angiogenesis is involved in processes such as wound healing response, embyrogenesis and ovarian follicle development

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

In disease states

A

Angiogenesis can play a role in disease progression with cancer the primary candidate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Cancer is the second leading cause of death worldwide

A

1 in 2 will get it
1 in 4 will die from it
Emphasising need to understand mechanism
To make new therapies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

The early work of Gimbrone (1972)

A

Demonstrated the ability of cancer cells to hijack angiogenesis in the absence of inflammation

Implanting cancer cells in an avascular site was shown to trigger vessel sprouting, essential for tumour growth

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Angiogenesis in cancer leads to

A

development of immature, structurally unsound blood vessels
Impaired nutrient and oxygen delivery

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Oncogenes

A

Mutated genes in cancer
Normal function in cell growth
Mutated leads to uncontrolled proliferation
KRAS and EGFR
Pro-angiogenic
Upregulate VEGF

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

VEGF

A

Potent angiogenic factor
HIF pathway target gene

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

HIF

A

Oxygen sensing
Cancer development
HIF stabilised in hypoxia
Hypoxia - VEGF transcription
Promotes angiogenesis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Tumour progression

A

Most tumours arise as avascular masses
Oxygen by diffusion
Become hypoxic - HIF - VEGF
Angiogenesis activated
Pathological angiogenesis
Intensifies hypoxia
Therapy resistance
Excessive angiogenesis promotes hypoxia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Metastasis

A

Angiogenesis provides an exit mechanism for cancer cells to invade other tissues and distant organs

Angiogenic switch activated by hypoxia
Dormant cancer cells regain tumourgenic potential

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Oxygen sensing pathways

A

mTOR
AMP/ADP
AMPK - mTOR
upstream reg of HIF-VEGF

Unfolded protein response - severe hypoxia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Blocking HIF and angiogenesis

A

Simultaneous blockade of HIF and angiogenesis
Improve patient outcome
Disrupt feed forward loop of HIF hypoxia and metastasis

HIF1 - digoxin
HIF2 - belzutifam
VEGF - bevacizuma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

LDM chemo

A

Small frequent dose
Well tolerated
Favourable safety profile
Patients ineligible for targeted therapies
Compared to MTD (adverse, necrosis, hypoxia, resistance, recurrance, mets)

17
Q

LDM in breast preclinical

A

LDM
Decreased hypoxia, angiogenesis and mets
Preclinical model of breast cancer
Lung metastasis

Cyclophosphamide
Capecitabine

18
Q

Maturation of intratumoural vessels

A

Enhance delivery of drugs to cancer cells
Decreased hypoxia related resistance

19
Q

Future directions

A

target pro-angiogenic oncogenes
angiogenic and oxygen sensing pathways
LDM - alleviate intratumoural hypoxia
promote vessel normalisation - drug delivery
sensitise hypoxic, resistant tumours

angiogenic and hypoxia response profiling
individualised combination therapies